Brandon Early is a seasoned drug developer with demonstrated expertise in aligning scientific strategy with operational scale. As President of Summit Clinical Research, he leads the organization in supporting sponsors, network sites, and CROs to advance metabolic drugs to market.

Before joining Summit, Brandon led global Project Management for ICON Biotech, formed through the acquisition of PRA Health Sciences. At PRA, he served as Therapeutic Area Head for hematology/oncology and drove key operational improvements in study start-up, CTMS implementation, and organizational design.

Earlier in his career, Brandon oversaw clinical development for Heat Biologics’ allogeneic cell therapy platform, managing clinical operations, regulatory strategy, and CMC coordination. He began his career as a study coordinator at the University of Virginia and later held project management roles at INC Research in both the U.S. and Europe. He holds both his undergraduate and master’s degrees from the University of Virginia.